WM (WM) Q3 2025 earnings review
Core Business Powers Record Margins, Overshadowing Healthcare Reset; Landmark 2026 Cash Flow Outlook Unveiled
WM delivered a strong Q3, with record-setting margins in its core Collection & Disposal business driving a 15% increase in operating EBITDA. The legacy business is firing on all cylinders, offsetting a managed revenue slowdown in the newly acquired WM Healthcare Solutions segment, where management is prioritizing customer retention and systems integration over near-term price hikes. Despite the healthcare revenue drag, WM raised its full-year margin guidance. The standout news was the early outlook for FY2026 free cash flow to approach $3.8 billion, a massive ~33% step-up from the 2025 forecast, signaling a major inflection point as years of investment in sustainability and the new healthcare platform begin to generate significant cash returns.
🐂 Bull Case
Management's forecast for free cash flow to approach $3.8 billion in FY26 signals a major inflection point where years of heavy capital spending will convert into substantial shareholder returns.
The legacy Collection & Disposal business achieved a record 38.4% adjusted operating EBITDA margin, demonstrating exceptional operational efficiency and pricing power that continues to drive the company's financial performance.
Despite a revenue reset, the WM Healthcare segment's margins are improving sequentially (15.3% -> 17.0% -> 17.5%), indicating that integration and synergy capture efforts are on track.
🐻 Bear Case
Revenue from the newly acquired healthcare business is tracking below initial expectations due to deferred price increases and customer credits, a necessary step for integration but a drag on near-term growth.
Recycled commodity prices fell nearly 35% YoY, and a $152 million impairment on a plastic recycling venture highlights the volatility and risk in this segment, even as automation provides an operational buffer.
⚖️ Verdict: 🟢
Bullish. While the healthcare revenue reset requires monitoring, it appears to be a well-managed, temporary issue. The exceptional, accelerating profitability of the core business combined with the landmark 2026 free cash flow forecast are the dominant themes. The outlook suggests WM is entering a new phase of cash generation, which should outweigh near-term integration pains.
Key Themes
A Landmark Year for Cash Flow Ahead: FY26 Outlook
The most significant update was management's early outlook for FY26 free cash flow to approach $3.8 billion. This represents a more than $900 million (or ~33%) step-up from the FY25 guidance midpoint of $2.85 billion. This acceleration is driven by the confluence of peaking capital investment in sustainability projects, a significant ramp-up in EBITDA contributions from these new assets, and growing synergies from the WM Healthcare acquisition. This signals a clear shift from a period of heavy investment to one of 'harvesting' returns.
Core 'Engine' Hits Record 38.4% Margin
The legacy Collection & Disposal business was the star of the quarter, with adjusted operating EBITDA margin expanding 100 basis points YoY to a record 38.4%. This performance was driven by a combination of disciplined pricing (6.0% core price), strong landfill volumes, and sustained cost optimization. Investments in technology and improved employee retention (driver/technician turnover at a record low 16.8%) are structurally lowering operating costs, proving the core business remains a powerful and improving earnings engine.
WM Healthcare Revenue Reset for Long-Term Gain
Full-year revenue guidance was trimmed, citing lower-than-expected revenue from WM Healthcare Solutions. Management is deliberately deferring price increases and issuing credits to customers to smooth the integration process and resolve legacy billing issues from the prior ERP system. While margins are improving sequentially, this top-line pressure contradicts the positive acquisition narrative and highlights that the integration is complex, requiring a focus on 'housekeeping' before aggressive growth can be pursued.
Sustainability Investments Prove Resilient
WM's recycling business provided a strong proof point for its automation strategy. Despite a nearly 35% YoY crash in recycled commodity prices, the segment's operating EBITDA grew by 18%. This demonstrates that investments in automation are successfully de-linking profitability from volatile commodity markets by structurally reducing labor costs. This resilience, combined with new RNG facilities coming online, validates the sustainability growth thesis.
Plastic Recycling Bet Triggers $152M Impairment
The company recorded a $152 million impairment charge to suspend operations at its Natura business, which focused on plastic film and wrap recycling. Management cited a 'significant deterioration of market pricing and demand for post-consumer plastics.' This is a tangible setback in its sustainability portfolio, demonstrating that not all green investments are immune to challenging market conditions and that some bets will not pay off as planned.
Industrial Volumes Inflect Positive for First Time Since 2022
In a positive sign for the broader economy, industrial collection volumes grew 1.2% in the quarter. Management noted this was the first positive print for the segment since 2022. While modest, this reversal from several quarters of declines suggests that the industrial part of the economy may be stabilizing or starting to recover.
Other KPIs
The quarter highlighted the divergent but positive stories of WM's two main segments. The WM Legacy business demonstrated its maturity and efficiency, expanding its adjusted operating EBITDA margin to an impressive 32.0%. Meanwhile, the newer WM Healthcare Solutions segment, while dilutive to the total, showed strong sequential progress, with its margin improving from 17.0% in Q2 to 17.5% in Q3 as integration efforts take hold.
The company continues to make progress on strengthening its balance sheet following the Stericycle acquisition. The leverage ratio improved sequentially to 3.3x. Management reiterated its commitment to return to its target range of 2.5x to 3.0x by the middle of 2026, funded by strong earnings growth and debt repayment.
Guidance
Decelerating vs. prior guidance. The outlook was lowered to the low end of the previous range, implying a slight reduction from expectations. This is primarily due to lower recycled commodity prices and the deliberate, managed slowdown in revenue recognition at WM Healthcare Solutions.
Accelerating vs. prior guidance. The margin range was raised and tightened from a prior 29.6% - 29.9%. This is a strong signal of confidence, indicating that the exceptional cost control and profitability in the core business are more than offsetting the commodity price headwinds and the dilutive impact of the healthcare acquisition.
Major Acceleration. This new forward-looking statement implies a ~33% increase over the FY25 midpoint. The growth is driven by lower capital expenditures on sustainability projects as the build-out phase winds down, combined with rising EBITDA contributions from both maturing sustainability assets and healthcare synergies. This outlook marks a significant inflection in the company's cash generation profile.